Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?-Reference-Cited by-同舟云学术

Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?

Published:2018-03-27 Issue:1 Volume:13 Page:38-40
ISSN:1574-8863
Container-title:Current Drug Safety
language:en
Short-container-title:CDS

Author:

Vasapollo Piero¹,Cione Erika²,Luciani Filippo³,Gallelli Luca⁴

Affiliation:

1. Department of General and Territorial Medicine, Azienda Sanitaria Provinciale, Crotone, Italy

2. Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Catanzaro, Italy

3. Infectious Disease Unit, Annunziata Hospital, Cosenza, Italy

4. Department of Health Science, University of Catanzaro and Operative Unit of Clinical Pharmacology and Pharmacovigilance, Mater Domini Hospital, Catanzaro, Italy

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Pharmacology,Toxicology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Telangiectasia Macularis Eruptiva Perstans in a 55-Year-Old Female With Type 2 Diabetes Mellitus;Cureus;2024-03-31

3. Association between sodium–glucose co-transporter 2 inhibitors and risk of psoriasis in patients with diabetes mellitus: a nationwide population-based cohort study;Clinical and Experimental Dermatology;2022-12-01

4. The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis;Metabolites;2022-10-17

5. Gliflozin ( SGLT2 inhibitor) induced vulvitis;International Journal of Dermatology;2022-10-17